Literature DB >> 22479016

Stability of Levothyroxine in Sodium Chloride for IV Administration.

Dawn K Strong1, Diane Decarie, Mary H H Ensom.   

Abstract

BACKGROUND: Levothyroxine by IV administration is often prescribed in the intensive care unit for the management of potential solid organ donors, following declaration of brain death and provision of consent for organ donation. Published data on the stability of levothyroxine in IV solutions are limited.
OBJECTIVE: To evaluate the physical compatibility and chemical stability, over a 24-h period, of 2 concentrations of levothyroxine in 0.9% sodium chloride with storage at room temperature and with exposure to or protection from light.
METHODS: Levothyroxine solutions (0.4 μg/mL and 2.0 μg/mL) were prepared in 50-mL minibags of 0.9% NaCl and stored at room temperature (25°C) with exposure to or protection from light. Samples were collected from each minibag at time 0 and after 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 8.0, 12.0, and 24.0 h. The samples were analyzed in triplicate with a validated stability-indicating high-performance liquid chromatography method using ultraviolet detection. A solution was considered stable if it maintained 90% of its initial concentration of levothyroxine. Changes in colour, clarity, and pH were assessed to determine the physical compatibility of the solutions.
RESULTS: All samples remained clear, colourless, and free of precipitate throughout the study, and there were no significant changes in pH. Based on the 95% confidence interval of the slope of the curve relating concentration to time determined by linear regression, solutions of levothyroxine with concentration 0.4 μg/mL would maintain at least 90% of the initial concentration for 16.9 h with exposure to light and for 18.0 h if kept in the dark. Solutions of levothyroxine with concentration 2.0 μg/mL would maintain at least 90% of the initial concentration for 6.5 h with exposure to light and for 12.0 h if kept in the dark, with 95% confidence.
CONCLUSIONS: Extemporaneously prepared solutions of levothyroxine in 0.9% NaCl can be expected to remain stable for at least 6.5 h if stored without protection from light and at least 12 h if stored in the dark. Stability is related to concentration, with more dilute solutions having greater stability.

Entities:  

Year:  2010        PMID: 22479016      PMCID: PMC3004701          DOI: 10.4212/cjhp.v63i6.963

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN: 0008-4123


  15 in total

Review 1.  Care of the potential organ donor.

Authors:  Kenneth E Wood; Bryan N Becker; John G McCartney; Anthony M D'Alessandro; Douglas B Coursin
Journal:  N Engl J Med       Date:  2004-12-23       Impact factor: 91.245

Review 2.  Medical management to optimize donor organ potential: review of the literature.

Authors:  Demetrios J Kutsogiannis; Giuseppe Pagliarello; Christopher Doig; Heather Ross; Sam D Shemie
Journal:  Can J Anaesth       Date:  2006-08       Impact factor: 5.063

3.  Stability-indicating assay, dissolution, and content uniformity of sodium levothyroxine in tablets.

Authors:  S L Richheimer; T M Amer
Journal:  J Pharm Sci       Date:  1983-11       Impact factor: 3.534

4.  Avoiding common flaws in stability and compatibility studies of injectable drugs.

Authors:  L A Trissel
Journal:  Am J Hosp Pharm       Date:  1983-07

5.  Hormonal resuscitation yields more transplanted hearts, with improved early function.

Authors:  John D Rosendale; H Myron Kauffman; Maureen A McBride; Franki L Chabalewski; Jonathan G Zaroff; Edward R Garrity; Francis L Delmonico; Bruce R Rosengard
Journal:  Transplantation       Date:  2003-04-27       Impact factor: 4.939

Review 6.  Hormonal therapy of the brain-dead organ donor: experimental and clinical studies.

Authors:  Dmitri Novitzky; David K C Cooper; John D Rosendale; H Myron Kauffman
Journal:  Transplantation       Date:  2006-12-15       Impact factor: 4.939

7.  High-performance liquid chromatographic assay for sodium levothyroxine in tablet formulations: content uniformity applications.

Authors:  R L Garnick; G F Burt; D A Long; J W Bastian; J P Aldred
Journal:  J Pharm Sci       Date:  1984-01       Impact factor: 3.534

8.  Stability indicating validated HPLC method for quantification of levothyroxine with eight degradation peaks in the presence of excipients.

Authors:  R B Shah; A Bryant; J Collier; M J Habib; M A Khan
Journal:  Int J Pharm       Date:  2008-04-20       Impact factor: 5.875

Review 9.  Management to optimize organ procurement in brain dead donors.

Authors:  L Mascia; I Mastromauro; S Viberti; M Vincenzi; M Zanello
Journal:  Minerva Anestesiol       Date:  2008-01-24       Impact factor: 3.051

10.  Stability of levothyroxine sodium 0.4 microg/mL in 0.9% sodium chloride injection.

Authors:  Kelli A Stadalman; Michael J Kelner; Kevin Box; Alex Dominguez; Joseph F Rigby
Journal:  Prog Transplant       Date:  2009-12       Impact factor: 1.065

View more
  1 in total

1.  Stability of propranolol in extemporaneously compounded suspensions.

Authors:  Mary H H Ensom; Jennifer Kendrick; Susan Rudolph; Diane Decarie
Journal:  Can J Hosp Pharm       Date:  2013-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.